Laboratory Test	Result	reference range
Serum Creatinine	1 mg/dl (88.4 μmol/L)	0.5-1.1 mg/dL (44-97 μmol/L)
BUN	9 mg/dl. (3.2 mmol/L)	10-20 mg/dl. (3.6-7.1 mmol/L)
Sodium	136 mEq/L (136 mmol/L)	136 to 145 mEq/L (136 to 145 mmol/L)
Potassium	6.1 mEq/L (6.1 mmol/L)	3.5 to 5 mEq/L (3.5 to 5 mmol/L)

The nurse reviews the lab values.

What questions can the nurse ask the client based on the lab results? Select all that apply.

A. Evaluate muscle strength every 4 hours:

While monitoring muscle strength is essential in assessing the client's response to treatment and potential side effects, checking it every 4 hours may not be necessary and can disrupt the client's rest. Assessing muscle strength as part of the overall neurological assessment at regular intervals is appropriate.

B. Monitor intake and output every 8 hours:

Monitoring intake and output is essential for assessing hydration status, but it is not directly related to the administration of baclofen. It is a routine nursing assessment and should not be tied specifically to this medication.

When administering the muscle relaxant baclofen by mouth (PO) to a client diagnosed with multiple sclerosis, the nurse should implement the following intervention:

C. Advise the client to move slowly and cautiously when rising and walking.

Explanation: Baclofen is a muscle relaxant that can cause drowsiness, dizziness, and muscle weakness as side effects. Therefore, clients taking baclofen should be advised to move slowly and cautiously when rising from a sitting or lying position and when walking. This helps prevent falls and injuries due to the medication's potential effects on coordination and muscle function.

D. Ensure the client knows to stop baclofen before using other antispasmodics:

It is essential for the client to be aware of their medications and potential interactions, but stopping baclofen or any medication should be done under the guidance of a healthcare provider. The nurse should educate the client about the importance of discussing all medications and potential interactions with their healthcare provider but should not instruct them to stop any medication without medical advice.

A. A warm room temperature:

The room temperature itself is not directly related to the effects of mydriatic medications, which primarily affect pupillary dilation and sensitivity to light.

B. A quiet, restful environment:

While a quiet environment can be beneficial for many clients, it is not specific to the needs of a client receiving a mydriatic medication.

C. Cool, humidified air:

The temperature or humidity of the air is not the primary concern when a client is on mydriatic medication. Reducing light exposure is the primary consideration.

The best environment for a client receiving a mydriatic medication is:

D. A dimly lit room.

Explanation: Mydriatic medications are drugs that cause pupil dilation. Pupil dilation results in increased sensitivity to light, which can lead to discomfort or glare when exposed to bright light. To minimize these effects and provide comfort to the client, it's best to place them in a dimly lit room where the intensity of the light is reduced.